Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03877068 · ClinicalTrials.gov registry record · NA
Dexcom G6 Intervention Study
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 185
- Enrollment target
NCT03877068: Completed NA study, sponsored by Emory University.
NCT03877068 is a NA study that has completed, run by Emory University. The registered enrollment target is 185 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03877068, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 185 participants
- Enrollment target
Study Summary
The study will assess if Continuous Glucose Monitoring (CGM) represents a better tool to guide healthcare providers in adjusting insulin therapy, by providing a more complete 24-hour assessment of glucose values compared to Point of Care (POC) testing, during hospitalization and after hospital discharge in general medicine and surgery patients with Type 2 Diabetes (T2D) and Type 1 Diabetes (T1D).
Primary Outcome
A random (non-fasting) blood glucose measurement of 140 mg/dL or less is considered normal, while a measurement of 200 mg/dL or more indicates diabetes.
Interventions
- DEVICE Dexcom G6 CGM - Continues Glucose Monitoring sensor system
- DIAGNOSTIC_TEST POC BG - Point-of-Care Blood Glucose monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2019-06-26 |
| Est. Completion | 2021-02-27 |
| Phase | NA |
What the finished NCT03877068 record still lists
NCT03877068 is an interventional study that assigns participants to a tested intervention. The registered 185 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Dexcom G6 CGM - Continues Glucose Monitoring sensor system is the first listed.
NCT03877068 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03877068 about?
NCT03877068 is a clinical study titled "Dexcom G6 Intervention Study". The study will assess if Continuous Glucose Monitoring (CGM) represents a better tool to guide healthcare providers in adjusting insulin therapy, by providing a more complete 24-hour assessment of glucose values compared to Point of Care (POC) testing, during hospitalization and after hospital disch...
What is the current status of trial NCT03877068?
This trial is currently completed. It is a NA study. The enrollment target is 185 participants. The study started on 2019-06-26. Estimated completion is 2021-02-27.
What interventions are being tested in trial NCT03877068?
The interventions under investigation include: Dexcom G6 CGM - Continues Glucose Monitoring sensor system (DEVICE), POC BG - Point-of-Care Blood Glucose monitoring (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03877068?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03877068's enrollment target sits among peer trials
185 580th of 2000 higher than 1,420 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04041154 · 185 participants · NA
Behavioral and Neural Representations of Subjective Effort Cost
- NCT04484272 · 185 participants · NA
A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease
- NCT05020860 · 185 participants · Phase 2
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
- NCT05793541 · 185 participants · NA
Just-in-time Interventions for Reducing Short-term Suicide Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI